申请人:Pharmacor Inc.
公开号:US06362165B1
公开(公告)日:2002-03-26
An hydroxyphenyl derivative selected from the group consisting of a compound of formula
and when a compound of formula I comprises a carboxylic acid group pharmaceutically acceptable salts thereof and when a compound of formula I comprises an amino group pharmaceutically acceptable ammonium salts thereof, wherein n is 1, 2 or 3, e is 1, 2 or 3, Hal represents a halogen atom (e.g. Cl, Br, F or I), p is 0, 1 or 2, r is 0, 1 or 2, X and X′ each independently represents a single bond, a saturated straight or branched hydrocarbon group of 1 to 4 carbon atoms or a straight or branched hydrocarbon group of 2 to 4 carbon atoms comprising a carbon to carbon double bond, Ra represents H or —CH3, and Raa represents H or —CH3; W may represent an amino acid residue or fragment. These compounds may be used to inhibit the activity of HIV integrase.
一种羟基苯基衍生物,选自以下化合物组:
当化合物I的结构中包含一个羧基时,其药用可接受盐;当化合物I的结构中包含一个氨基时,其药用可接受铵盐。其中,n为1、2或3,e为1、2或3,Hal代表卤素原子(如Cl、Br、F或I),p为0、1或2,r为0、1或2,X和X′各自独立代表单键,由1至4个碳原子组成的饱和直链或支链烃基,或由2至4个碳原子组成的直链或支链烃基,其中包含碳-碳双键,Ra代表H或—CH3,Raa代表H或—CH3;W可以代表氨基酸残基或片段。这些化合物可用于抑制HIV整合酶的活性。